Filter
400
Text search:
algorithm
Featured
Recommendations
47
New Publications
87
Language
Document type
No document type
199
Guidelines
85
Studies & Reports
55
Manuals
30
Strategic & Response Plan
10
Training Material
9
Situation Updates
5
Fact sheets
4
Infographics
3
Countries / Regions
India
25
Western and Central Europe
16
South Africa
15
Global
15
Kenya
12
Rwanda
11
Ethiopia
10
Eastern Europe
10
Latin America and the Carribbean
8
Nigeria
7
Tanzania
7
Philippines
5
Ukraine
5
Ghana
4
Uganda
4
Nepal
4
Zambia
4
Bangladesh
4
South–East Asia Region
4
Liberia
3
Senegal
3
Malawi
3
Namibia
3
Lesotho
3
East and Southern Africa
3
West and Central Africa
3
Africa
3
Guinea
2
Sierra Leone
2
Cameroon
2
Zimbabwe
2
Myanmar / Burma
2
Asia
2
Georgia
2
Morocco
1
USA
1
Pakistan
1
Afghanistan
1
Germany
1
Cambodia
1
Mozambique
1
Argentina
1
Eswatini/ Swaziland
1
Colombia
1
Botswana
1
Sri Lanka
1
Middle East and North Africa
1
Western Pacific Region
1
Bhutan
1
Tajikistan
1
Russia
1
Estonia
1
Moldova
1
Iran
1
Gabon
1
Turkmenistan
1
Mauritius
1
Authors & Publishers
Publication Years
Category
Countries
131
Clinical Guidelines
61
Women & Child Health
19
Public Health
18
Pharmacy & Technologies
11
Capacity Building
5
Key Resources
5
Toolboxes
TB
59
HIV
47
Mental Health
32
NTDs
31
COVID-19
20
AMR
13
Caregiver
11
Rapid Response
9
NCDs
9
Zika
6
Planetary Health
6
2.0 Rapid Response
6
Ebola & Marburg
5
Polio
4
Refugee
4
Disability
3
Pharmacy
3
Conflict
2
Specific Hazards
2
Natural Hazards
1
Global Health Education
1
Health Financing Toolbox
1
Malaria
1
Standard Treatment Guideline
Session outline
•Introduction to epilepsy.
•Assessment of epilepsy.
•Management of epilepsy.
•Follow-up of a person with epilepsy.
•Review or materials and skills.
2nd edition.This updated publication provides programme managers with a user-friendly tool that can: (i) analyse and draw conclusions from historic dengue datasets; (ii) identify appropriate alarm indicators that can predict forthcoming outbreaks at smaller spatial scales; and (iii) use these result
...
Antimicrobial resistance is one of the most important threats to the health worldwide. Antimicrobial resistance or drug resistance is the reduction of the pharmaceutical effects of a drug against a disease or reduction of its effectiveness in improving the clinical signs of a disease. Antimicrobial
...
This publication provides directions for a logical, evidence informed approach to selecting, developing, implementing and monitoring population-based interventions within the context of the double-burden of malnutrition in South-East Asia. The focus of this guide is on processed or ultra-processed p
...
Trypanosoma cruzi is the etiological agent of Chagas disease (CD), considered one of the most important parasitic infections in Latin America. Between 25 and 90 million humans are at infection risk via at least one of multiple infection mechanisms. Under natural conditions, the principal transmissio
...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr
...
PLoS Negl Trop Dis 18(7): e0012282.
This review highlights common diagnostic
approaches for detecting schistosomiasis in field and clinical settings, major challenges,
and provides new and novel opportunities and diagnosis pathways that will be critical in sup-
porting elimination of schistosomi
...
An Evidence-Based Treatment Guide for Clinicians
Health ministries currently lack effective tools for monitoring and evaluation of schistosomiasis control programmes. Egg detection can be used, but the cost, challenges of obtaining samples, and the need for trained personnel and equipment limit the frequency of monitoring. The purpose of this TPP
...
Prepared as an outcome of ICMR Subcommittee on Larynx & Hypopharynx Cancers | This consensus document on management of larynx and hypopharynx cancers summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecular markers and re
...
